Gurinder Singh

I am a molecular biologist with 8+ years of research experience in cardiovascular research. I am working as a Postdoctoral Researcher Fellow at Harvard Medical School and my main research focus is to use patient-specific iPSC-derived cardiomyocytes to study congenital heart disease. I worked as a Postdoctoral Research Fellow at University of Houston from 2017-2019 and explored the role of TMAO, Visfatin and Nicotine in endothelial dysfunction and podocyte injury using in-vitro as well as using mice atherosclerotic and nephrectomy model. I received my PhD from post graduate institute of medical education and research, India. I investigated the role of microRNAs and promoter methylation in diabetes associated cardiac hypertrophy in both primary cardiomyocytes as well as in rat model of diabetes associated cardiac hypertrophy.

Education

• Doctor of Philosophy - PhD Post Graduate Institute of Medical Education and Research, Chandigarh (2009 — 2015)
• Master of Science - MS Panjab University (2007 — 2009)
• Bachelor of Science - BS Panjab University

Companies

• Research Fellow Harvard Medical School (2019)
• Research Fellow Boston Children's Hospital, Harvard Medical School (2019)
• Post Doctoral Fellow University of Houston (2017 — 2019)
• Senior Demonstrator Post Graduate Institute of Medical Education and Research (2016 — 2017)
• Assistant Professor Lovely Professional University (2016 — 2016)
• Research Fellow Post Graduate Institute of Medical Education and Research, Chandigarh , India (2010 — 2015)